iifl-logo

Pramodini Medicare Ltd Company Summary

Add as a Preferred Source on Google
111.55
(-2.83%)
Aug 31, 2026|10:23:54 AM

Pramodini Medicare Ltd Summary

Pramodini Medicare Limited was originally incorporated on September 12, 2000 as Pramodini Medicare Private Limited with the Registrar of Companies, Andhra Pradesh. Thereafter, the status of the Company changed to public limited Company and the name was changed to Pramodini Medicare Limited vide fresh certificate of incorporation dated November 12, 2025. Company was originally incorporated in the year 2000 with the objective to provide diagnostic services.

The Company provide a range of technology-enabled diagnostic services such as radiology, clinical laboratory and nuclear medicine service to public hospitals, private hospitals, certain PSU (Public Sector Undertaking) of Government of India and medical colleges across tier I, tier II and tier III cities throughout India. Diagnostic services include a comprehensive range of offerings: (i) Radiology which covers Magnetic Resonance Imaging (MRI), Computed Tomography (CT scan), X- ray, Ultrasound with colour doppler, Mammography, DEXA Scan and Intervention Radiology, (ii) Clinical Laboratory which includes Haematology, Micro-Biology, Immunology, Pathology & Bio-Chemistry and (iii) Nuclear Medicine which includes PET-CT (Positron Emission Tomography-Computed Tomography), SPECT (Single Photon Emission Computed Tomography) and Nuclear therapy. The Company provide teleradiology services through its registered office situated at Vijayawada which functions on a 24x7 basis throughout the year.

It provide healthcare services for core testing, patients diagnosis, disease prevention and monitoring of various health conditions. The services includes both routine and specialized tests, which are used for prediction, early detection, diagnostic screening, confirmation and/or monitoring of diseases.Apart from these, the business operates across four key models mainly the Public Private Partnership (with government hospitals and government teaching hospitals), Private Private Partnership (with private sector hospitals), Strategic Partnership with PSUs (Public Sector Undertakings) Government of India and Private Centres (standalone centre).The company has filed a Draft Prospectus with SEBI for the IPO by issuing the aggregate of 58,51,200 equity shares of Rs 10 each, which consist a fresh issue of 53,50,000 equity shares and the offer for sale of 5,00,400 equity shares.
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2026, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.